Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation

Eman F. Khaleel, Ghada A. Abdel-Aleem
  • Archives of Physiology and Biochemistry, February 2018, Taylor & Francis
  • DOI: 10.1080/13813455.2018.1437638

The authors haven't yet claimed this publication.

Read Publication


In partnership with: